Flack flies over my Restless Legs Syndrome posts.

Last July I first wrote on this site about GlaxoSmithKline's TV campaign for Requip, which started out as a commercial describing Restless Legs Syndrome in detail--it's a common practice among the pharmaceutical companies, to essentially advertise the diagnosis ahead of the drug. Lately, two site visitors have taken me to task for my flippant approach in my first post--you can read the post and the comments here. One of the commenters also posted the same comment on my most recent Requip post, below. I responded below his/her post.

I don't like to upset people, particularly those who suffer from painful disorders. I don't mind upsetting pharmaceutical companies, most of which would benefit from an ethical marketing department swamp-draining operation. I do apologize to any sufferers of RLS I've offended. I'd also feel better about hearing from you if you didn't choose to be anonymous--so I'd have a way of finding out that I'm not being heckled by a pharmaceutical PR agent. And, I'd appreciate it if you'd attend to the clarity of my messages--that I'm not finding fault with patients, nor even drugs, but rather drug marketing techniques. Obviously, if you're suffering, no price is too high nor risk too great. If the drug companies acted more like they were sensitive to the responsibility this situation produces, I think we'd all feel a lot better.